Melanoma is a highly aggressive skin cancer, especially in advanced stages.
While current treatments such as targeted therapies and immunotherapies have made significant progress, challenges like drug resistance and limited effectiveness in some patients persist.
Therefore, ongoing development of novel therapies, particularly for late-stage melanoma, is crucial.
